Qingdao Vland Biotech Co Ltd Net Asset Quality Index
Qingdao Vland Biotech Co Ltd net asset quality index. Qingdao Vland Biotech Co Ltd (603739) has a Net Asset Quality Index of 62.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.04 Billion minus total liabilities of CN¥1.14 Billion yields net assets of CN¥1.90 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Qingdao Vland Biotech Co Ltd shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Qingdao Vland Biotech Co Ltd (2014–2024)
Net asset quality index of Qingdao Vland Biotech Co Ltd from 2014 to 2024. This chart shows how Qingdao Vland Biotech Co Ltd's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 62.5%, representing net assets of CN¥1.90 Billion against total assets of CN¥3.04 Billion CNY. Check Qingdao Vland Biotech Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Qingdao Vland Biotech Co Ltd Net Asset Quality Index by Year (2014–2024)
Qingdao Vland Biotech Co Ltd net asset quality index by year from 2014 to 2024. The table below presents the year-by-year Net Asset Quality Index for Qingdao Vland Biotech Co Ltd from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 603739 market cap overview.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 62.7% | CN¥1.87 Billion | CN¥2.98 Billion | CN¥1.11 Billion | ▲ +2.6 pp |
| 2023 | 60.2% | CN¥1.83 Billion | CN¥3.03 Billion | CN¥1.21 Billion | ▼ -7.1 pp |
| 2022 | 67.2% | CN¥1.73 Billion | CN¥2.58 Billion | CN¥844.93 Million | ▼ -8.6 pp |
| 2021 | 75.9% | CN¥1.69 Billion | CN¥2.22 Billion | CN¥536.18 Million | ▼ -1.0 pp |
| 2020 | 76.8% | CN¥1.12 Billion | CN¥1.45 Billion | CN¥336.22 Million | ▼ -3.7 pp |
| 2019 | 80.6% | CN¥1.03 Billion | CN¥1.28 Billion | CN¥248.99 Million | ▲ +13.8 pp |
| 2018 | 66.8% | CN¥631.38 Million | CN¥945.32 Million | CN¥313.94 Million | ▼ -0.3 pp |
| 2017 | 67.1% | CN¥592.53 Million | CN¥883.55 Million | CN¥291.02 Million | ▼ -0.3 pp |
| 2016 | 67.4% | CN¥557.97 Million | CN¥827.92 Million | CN¥269.96 Million | ▲ +4.2 pp |
| 2015 | 63.2% | CN¥519.36 Million | CN¥821.63 Million | CN¥302.27 Million | ▲ +4.5 pp |
| 2014 | 58.7% | CN¥466.26 Million | CN¥794.79 Million | CN¥328.53 Million | — |